Ads
related to: phase 1b clinical trial- Follow the Blog
Get The Latest News
And Updates from The James
- Find a Location
Get Directions To The James
Locations in Central Ohio
- Find A Doctor
Browse The James Top Doctor By
Specialty, Cancer Type or Name
- New Diagnostic Center
Same or Next Day Access to
Cancer Diagnostic Experts
- Treat Cancer & Diagnose
The James is Home to
World-Renowned Cancer Experts
- Immunotherapy Management
Proactively mitigating side effects
Well-being beyond cancer treatment
- Follow the Blog
Search results
Werewolf Therapeutics to Present Data from Ongoing Phase 1/1b Clinical Trial of WTX-124 as...
Benzinga· 3 days ago(the "Company" or "Werewolf") HOWL, an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body's immune system ...
TuHURA reports breakthrough in cancer vaccine trial By Investing.com
Investing.com· 18 hours agoTherapeutics, Inc. (NASDAQ:KTRA), has announced positive results from a Phase 1b trial of its...
...Innovent Delivers Oral Presentation of Clinical Data of A Randomized Controlled Phase 1b Study...
KOIN News 6 Portland· 1 day ago("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and...
...Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0, a...
Morningstar· 23 hours ago(Nasdaq:KTRA) ("Kintara"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced positive results from the primary analysis of TuHURA's ...
TiumBio Presents Phase 1b Interim Results for TU2218 in Combination with Pembrolizumab at ASCO 2024...
KOLR - KSFX Ozarks· 3 days agoTiumBio Co., Ltd. (Kosdaq: 321550), a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapeutics for patients with rare and incurable ...
The Sustained, Slow Declining, Blood Concentration Profile of NV-387 Enables Infrequent Dosing for...
St. Joseph News-Press· 1 hour agoThe Company has found that its lead nanoviricide broad-spectrum antiviral drug candidate NV-387,...
Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors...
The Pendulum· 3 days agoEli Lilly and Company (NYSE: LLY) today announced updated data from the Phase 1/2 clinical trial evaluating olomorasib as a monotherapy ...
Alligator Bioscience's Phase 2 mitazalimab Pancreatic Cancer Data Published in The Lancet Oncology
Morningstar· 1 day agoLUND, SE / ACCESSWIRE / June 03, 2024 / Alligator Bioscience (STO:ATORX)Publication in world-leading clinical oncology journal validates the quality and potential implications ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 6 days agoImmunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating ...
...Pathology and AI Communications and Abstracts at the International Liver Congress — EASL 2024,...
Digital Journal· 23 hours ago...Corp in Revolutionary Room Temperature SPAD Technology TuHURA Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and...
